Moss Adams Wealth Advisors LLC Makes New $30.84 Million Investment in SPDR S&P Biotech ETF $XBI

Moss Adams Wealth Advisors LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, HoldingsChannel.com reports. The institutional investor acquired 195,591 shares of the exchange traded fund’s stock, valued at approximately $30,841,000. SPDR S&P Biotech ETF comprises about 2.0% of Moss Adams Wealth Advisors LLC’s portfolio, making the stock its 11th largest position.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MGO One Seven LLC boosted its stake in SPDR S&P Biotech ETF by 4.4% in the 3rd quarter. MGO One Seven LLC now owns 5,225 shares of the exchange traded fund’s stock worth $824,000 after buying an additional 222 shares during the last quarter. Americana Partners LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 1.1% during the 3rd quarter. Americana Partners LLC now owns 8,080 shares of the exchange traded fund’s stock valued at $1,274,000 after acquiring an additional 90 shares in the last quarter. Aprio Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 65.9% in the third quarter. Aprio Wealth Management LLC now owns 2,138 shares of the exchange traded fund’s stock valued at $337,000 after buying an additional 849 shares in the last quarter. Modera Wealth Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 1.8% during the third quarter. Modera Wealth Management LLC now owns 21,035 shares of the exchange traded fund’s stock worth $3,317,000 after purchasing an additional 377 shares in the last quarter. Finally, State of Wyoming acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $62,000.

SPDR S&P Biotech ETF Trading Down 1.1%

SPDR S&P Biotech ETF stock opened at $155.98 on Friday. The stock has a market cap of $10.72 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52 week low of $106.30 and a 52 week high of $169.89. The stock has a 50 day moving average of $156.60 and a 200-day moving average of $141.58.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.